“…Cells derived from iPSCs more closely recapitulate human biology than immortalized cells (Moffat et al, 2017; Scannell and Bosley, 2016). These derived cells have been used for disease modeling (Judge et al, 2017; Lan et al, 2013; Pérez-Bermejo et al, 2020; Ribeiro et al, 2017; Sharma et al, 2017; Sun et al, 2012), proposed for drug discovery (Carlson et al, 2013; Grskovic et al, 2011; Robinton and Daley, 2012), and used to assess arrhythmogenic and structural liabilities of drugs (Guo et al, 2011; Maddah et al, 2020). Additionally, iPSCs can be derived from patients carrying deleterious mutations and genetically modified using nucleases (Judge et al, 2017; Kime et al, 2016; Mandegar et al, 2016; Miyaoka et al, 2012).…”